NCT01978158View on ClinicalTrials.gov

Effects of Oxygen Status on Endotoxemia Induced Inflammation and Hypoxia Inducible Factor-1α

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
HypoxiaNormoxiaHyperoxia
Interventions
DRUG

Lipopolysaccharide

LPS is used to elicit an inflammatory response in all subjects

Trial Locations (1)

6500HB

Intensive Care Medicine, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT01978158 - Effects of Oxygen Status on Endotoxemia Induced Inflammation and Hypoxia Inducible Factor-1α | Biotech Hunter | Biotech Hunter